Thank you for signing up. Check your email, your white paper is on the way.

About Isogenica 

Isogenica is a biotechnology contract research organisation (CRO) specialised in small-format antibody discovery.
In particular, we focus on VHH – single-domain antibodies that offer exceptional robustness, flexibility, and scalability across varied therapeutic and diagnostic applications.

Combining the largest and most diverse synthetic VHH libraries available with our proprietary, cell-free CIS display technology means that these uniquely vast libraries can reach their full potential.

Our expert scientists tailor-make each project, allowing us to provide industry-disrupting antibody solutions to partners in around half the time of a traditional animal immunisation campaign.